Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 9.07M P/E - EPS this Y - Ern Qtrly Grth -
Income -15.97M Forward P/E -0.18 EPS next Y 54.10% 50D Avg Chg 1.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -15.00%
Dividend N/A Price/Book 1.39 EPS next 5Y - 52W High Chg -75.00%
Recommedations 2.00 Quick Ratio 0.22 Shares Outstanding 32.15M 52W Low Chg 257.00%
Insider Own 1.85% ROA -224.00% Shares Float 31.04M Beta 1.05
Inst Own 0.45% ROE - Shares Shorted/Prior 364.58K/107.92K Price 2.18
Gross Margin - Profit Margin - Avg. Volume 475,130 Target Price 0.50
Oper. Margin - Earnings Date Nov 13 Volume 51,264 Change 1.87%
About CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma multiforme. CNS Pharmaceuticals, Inc. has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center, as well as a collaboration and asset purchase agreement with Reata Pharmaceuticals, Inc. The company was incorporated in 2017 and is based in Houston, Texas.

CNS Pharmaceuticals, Inc. News
11/18/24 CNS Pharmaceuticals Announces Abstract Accepted for Poster Presentation at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024)
11/15/24 CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results
11/04/24 CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment
11/01/24 CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
10/23/24 CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
10/10/24 CNS Pharmaceuticals Participates in Virtual Investor KOL Connect Segment
10/08/24 CNS Pharmaceuticals to Participate in the 2024 Healthcare Virtual Summit Presented by Maxim Group LLC
09/23/24 CNS Pharmaceuticals to Present at the 24th Annual Biotech in Europe Forum
09/12/24 CNS Pharmaceuticals Regains Compliance with Nasdaq Equity Requirement
09/04/24 CNS Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
09/03/24 IBN Announces Latest Episode of The BioMedWire Podcast featuring John Climaco, CEO of CNS Pharmaceuticals Inc.
08/27/24 CNS Pharmaceuticals to Participate in at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
08/22/24 CNS Pharmaceuticals to Participate in Virtual Investor CEO Connect Segment
08/15/24 CNS Pharmaceuticals Reports Second Quarter 2024 Financial Results
07/30/24 CNS Pharmaceuticals Expands Pipeline with In-License of Late Stage, Novel Potential Blood Brain Barrier Permeable Abeotaxane for Treatment of Brain Malignancies
07/25/24 CNS Pharmaceuticals Announces Acceptance of Abstract for Poster Presentation at the 2024 SNO/ASCO CNS Cancer Conference
07/16/24 CNS Pharmaceuticals to Participate in the Virtual Investor Closing Bell Series
07/03/24 CNS Pharmaceuticals Announces Pricing of Registered Direct Offering and Concurrent Private Placement
06/10/24 CNS Pharmaceuticals Files Registration Statement for $9.2 Million Share, Warrant Offering -- Shares Fall
06/03/24 CNS Pharmaceuticals Announces Reverse Stock Split
CNSP Chatroom

User Image ZeroDark0800 Posted - 57 minutes from now

$CNSP

User Image Profitrip Posted - 20 minutes from now

$CNSP .1236> previous close / on my daily squeeze scan

User Image Gurkdipa69 Posted - 6 minutes ago

$CNSP close at $.13. Higher highs and lower lows!

User Image rj_trades Posted - 29 minutes ago

$CNSP trolling penny stocks about their RS’s is so fucking boring, get a life, come up with a better topic, snooze

User Image PelosiQT Posted - 31 minutes ago

$CNSP @Ctailor123 Looks like 15th of Neveruary

User Image Ctailor123 Posted - 38 minutes ago

$CNSP when is the reverse split?

User Image bhas007 Posted - 50 minutes ago

$CNSP penny stks below 1 not moving to one.big stks from 20 range to moving 40 .,50 why this difference

User Image LillianGreene_ Posted - 55 minutes ago

$CERO $CNSP $TNXP join this party 😏

User Image I_H8_SHORTS Posted - 57 minutes ago

$CNSP How bout some sweet after the bell news!

User Image whistlah Posted - 1 hour ago

@The_Assassin how’s your $CNSP vibe heading to tomorrow buddy?? Considering getting in. Keep up the good work btw. Appreciated!

User Image Timeintheseat Posted - 1 hour ago

$CNSP

User Image MarketMasterMind Posted - 1 hour ago

$NCPL | $CNSP gaps to fill after hours in both 🤑Ⓜ️

User Image I_H8_SHORTS Posted - 1 hour ago

$CNSP MM every trick in the book to slow buying. My BID not showing.

User Image mraustin9 Posted - 1 hour ago

$CNSP @warrants_Moon is a pumper / bagholder

User Image I_H8_SHORTS Posted - 1 hour ago

$CNSP BCTX trades at a market cap of 38 million with Phase I trial. This is close to approval and trades at a MC of 7 million for a Multi-Billion $+ Drug close to approval. SMH

User Image I_H8_SHORTS Posted - 1 hour ago

$CNSP Yup.. no shady trading here.. Nothing but shady MM manipulation...

User Image warrants_Moon Posted - 1 hour ago

$CNSP all these shares at .1311 lol

User Image Matty_Buffalo_Benj Posted - 1 hour ago

$CNSP looking good heading into power hour

User Image stocktwits_AJ Posted - 1 hour ago

$CNSP if you need $50 we give it to you just don't sell:)

User Image stocktwits_AJ Posted - 1 hour ago

$CNSP be crazy to sell. Best yet to come. We held all this time for nothing?

User Image warrants_Moon Posted - 2 hours ago

$CNSP do the opposite of this guy and you’ll make money!!

User Image MoneyPennyStocks Posted - 2 hours ago

$CNSP FUN FACT TIME!: Notice how almost ALL pharm stocks are penny stocks and shorted to the ground? There is a reason, R&D companies often fail or get acquired in a bankruptcy, this is why they are shorted, because you 100% know they will dilute to raise cash for more research since they often do not sell product until it can be tested and to the market. In most cases that product is already in contract with another company. Keep this in mind when someone says this stock (pharma stock) is about to go.....chances it wont.

User Image rj_trades Posted - 2 hours ago

$CNSP hangin. no rush.

User Image mraustin9 Posted - 2 hours ago

$CNSP here is the dump

User Image MoneyPennyStocks Posted - 2 hours ago

$CNSP Horrible entry....my god man you need help seeing charts?

User Image ITradeItToMakeIt Posted - 2 hours ago

$CNSP Was standing in formation when this hit 0.17… of course. Avg : 0.1334

User Image youbi336 Posted - 2 hours ago

$CNSP I added a bunch and am all set for tomorrow! Shorts, please know that whatever you sold me isn't coming back into the pool until this thing is above $10.0! You can try to cover from someone else ;)

User Image Gurkdipa69 Posted - 2 hours ago

$CNSP great consolidation. When this float gets locked up we run!

User Image MoneyPennyStocks Posted - 2 hours ago

$CNSP You should meet more people, then you truly will start to understand we are living in hell right now. This planet IS hell, slaves everywhere, murder, rape. Dude you are in hell, welcome to hell.

User Image warrants_Moon Posted - 2 hours ago

$CNSP wrong way shorts!

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Gumulka Jerzy Director Director Feb 01 Buy 0.30 33,333 10,000 43,006 02/06/24
Evans Carl Anthony Director Director Feb 01 Buy 0.30 33,333 10,000 33,458 02/06/24
Downs Christopher Chief Financial Offi.. Chief Financial Officer Feb 01 Buy 0.30 66,666 20,000 103,438 02/06/24
Climaco John M Chief Executive Offi.. Chief Executive Officer Feb 01 Buy 0.30 166,666 50,000 215,676 02/06/24
Downs Christopher Chief Financial Offi.. Chief Financial Officer Aug 22 Buy 1.2658 27,000 34,177 36,772 08/23/23
Climaco John M Chief Executive Offi.. Chief Executive Officer Aug 16 Buy 1.798 2,750 4,944 49,010 08/16/23
Priebe Waldemar 10% Owner 10% Owner Dec 06 Sell 1.46 94,298 137,675 156,807 08/01/23
Downs Christopher Chief Financial Offi.. Chief Financial Officer Apr 17 Buy 3.20 3,100 9,920 9,251 04/18/23
Gumulka Jerzy Director Director Apr 10 Buy 0.74 7,173 5,308 7,173 04/17/23